Synthesis of a new type of "bent" heterocyclic benzimidazolo-pyridazinones

DOI: 10.1016/0223-5234(93)90006-Z

Source and publish data:

European Journal of Medicinal Chemistry p. 141 - 148 (1993)

Update date:2022-08-05

Topics:

Authors:

Jonas, R

Pruecher, H

Wurziger, H

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0223-5234(93)90006-Z

The synthesis of some new heterocyclic benzimidazolo-pyridazinines starting from 2,1,3-benzothiadiazole-4-carboxaldehyde 2 is described.Biological evaluation of all new compounds proved them to be inhibitors of phosphodiesterase III with no marked positiv

Full text of DOI:10.1016/0223-5234(93)90006-Z

Products guided by the article

Product name:6-(2,3-diaminophenyl)-5-methyl-2,3,4,5-tetrahydro-pyridazin-3-one

Cas No:151869-76-0

R&D Labs maybe for 151869-76-0

BOC Sciences

website:https://www.bocsci.com/

Contact:1-631-485-4226

Address:Ramsey Road
VanderArk International Limited

Contact:86-10-82437576

Address:Qing He
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd

Contact:+86-517-86283327

Address:9 North Hantai Road, Huaian, China
Onlychem (Jinan)Biotech Co.,Ltd

Contact:86-531-83175885

Address:No. 44, Honglou South Road, Jinan,China
Chongqing Werlchem Fine Chemical Co. Ltd

Contact:+86-23-67521957

Address:NO.15,Fortune Road,Yubei District,401121,Chongqing,China

Relevant to this article

Organoselenium(ii) halides containing the pincer 2,6-(Me ₂NCH₂)₂C₆H₃ ligand-an experimental and theoretical investigation

Doi:10.1039/c3dt52886c
(2014)
Seven novel coordination polymers constructed by rigid 4-(4-carboxyphenyl)- terpyridine ligands: Synthesis, structural diversity, luminescence and magnetic properties

Doi:10.1039/c3dt52500g
(2014)
Pictet-Spengler reactions of oxetan-3-ones and related heterocycles

Doi:10.1016/j.tetlet.2013.11.077
(2014)
Structure/Function Relationships in Ligand-Based SO2/O2 Conversion to Sulfate As Promoted by Nickel and Palladium Thiolates

Doi:10.1021/ic00129a013
()
3-[(2R)-amino-2-phenylethyl]-1-(2,6-difluorobenzyl)-5-(2-fluoro-3- methoxyphenyl)-6-methylpyrimidin-2,4-dione (NBI 42902) as a potent and orally active antagonist of the human gonadotropin-releasing hormone receptor. Design, synthesis, and in vitro and in vivo characterization

Doi:10.1021/jm049218c
(2005)
Doi:10.1021/jo01266a050
(1968)

Article Doi